Literature DB >> 22049541

Cervical cancer screening: Less testing, smarter testing.

Xian Wen Jin1, Andrea Sikon, Belinda Yen-Lieberman.   

Abstract

In its 2009 recommendations for cervical cancer screening, the American College of Obstetricians and Gynecologists (ACOG) calls for less-frequent but smarter screening that integrates testing for human papillomavirus (HPV) infection with the Papanicolaou (Pap) test. We review the recommendations from this and other organizations and how and why they are evolving.

Entities:  

Mesh：

Year:  2011        PMID： 22049541     DOI： 10.3949/ccjm.78a.11033

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  5 in total

1.  Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies.

Authors:  Laureen Ribassin-Majed; Rachid Lounes; Stephan Clémençon
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

2.  High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.

Authors:  Shu-Yan Liu; Peng-Sheng Zheng
Journal:  Oncotarget       Date:  2013-12

3.  Renal metastasis from cervical carcinoma presenting as a renal cyst: A case report.

Authors:  Gang Fan; Y U Xie; Xiaming Pei; Jian Lei; Mingji Ye; Gongqian Zeng; Feiping Li; Yingying Xiong; Weiqin Han
Journal:  Oncol Lett       Date:  2015-09-09       Impact factor: 2.967

4.  Annual Papanicolaou screening for 5 years among human papillomavirus-negative women.

Authors:  Karl Ulrich Petry; Franziska Rinnau; Gerd Böhmer; Bettina Hollwitz; Alexander Luyten; Nina Buttmann; Martin Brünger; Thomas Iftner
Journal:  BMC Cancer       Date:  2013-08-09       Impact factor: 4.430

Review 5.  Diagnostic Test Accuracy of First-Void Urine Human Papillomaviruses for Presence Cervical HPV in Women: Systematic Review and Meta-Analysis.

Authors:  Peter Bober; Peter Firment; Ján Sabo
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.